Cidara Therapeutics to Host Investor Day on April 6, 2017
March 29, 2017 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 29, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, will host an Investor Day...
Cidara Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results
March 15, 2017 17:22 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, March 15, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Provides Corporate Update and Reports Third Quarter 2016 Financial Results
November 10, 2016 16:10 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 10, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
Cidara Therapeutics to Present at the Stifel 2016 Healthcare Conference
November 08, 2016 16:05 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 08, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced it will...
Cidara Therapeutics and Square 1 Bank Announce $20 Million Credit Facility
November 02, 2016 07:30 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Nov. 02, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives and immunotherapies to treat fungal and other...
Cidara Therapeutics Announces Closing of Public Offering of Common Stock, Including Exercise of Underwriter’s Option to Purchase Additional Shares
October 13, 2016 09:20 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 13, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the closing...
Cidara Therapeutics Announces Pricing of Public Offering of Common Stock
October 07, 2016 09:00 ET
|
Cidara Therapeutics, Inc.
SAN DIEGO, Oct. 07, 2016 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
C3 Jian Completes Second Phase 2 Clinical Trial of Anti-Cavity Drug
July 13, 2015 06:00 ET
|
C3 Jian, Inc.
LOS ANGELES, July 13, 2015 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a biotechnology company focused on reengineering the human microbiome to deliver novel healthcare products, announced it has preliminary...
C3 Jian Closes $60M Series D Financing
March 17, 2014 15:12 ET
|
C3 Jian, Inc.
LOS ANGELES, March 17, 2014 (GLOBE NEWSWIRE) -- C3 Jian, Inc., a private company focused on developing proprietary drugs with an initial focus on improving oral healthcare, announced today the close...
New Functional Coatings Provide Under-Appreciated Business Opportunities
August 15, 2013 07:30 ET
|
Lux Research
BOSTON, MA--(Marketwired - Aug 15, 2013) - Advances in materials science and nanotechnology have created several new functionalities in coatings, going beyond their original basic protective and...